Esmée M. Bordewijk - Gynecology

Author Information

Esmee M. Bordewijk is affiliated with the Department of Obstetrics and Gynecology at Monash University in Clayton, Australia, and the Centre for Reproductive Medicine at Amsterdam UMC in Amsterdam, the Netherlands. Her research primarily focuses on women's health, particularly in the areas of reproductive medicine and research integrity.

Research Contributions

Esmee M. Bordewijk has made significant contributions to the field of gynecology and reproductive medicine. Her work often addresses research misconduct and data integrity in randomized controlled trials. She has also explored various aspects of ovulation induction in women with polycystic ovary syndrome (PCOS), including the effectiveness of laparoscopic ovarian drilling and the impact of different treatments on the endometrium. Her research is vital in ensuring the reliability and validity of clinical trials in women's health.

Aliases

Esmee M. Bordewijk is known by several aliases, including E M Bordewijk, E Bordewijk, Esmée M Bordewijk, Esmée M. Bordewijk, Esmee M Bordewijk, Esmee Bordewijk, and Esmee M. Bordewijk.

Publication and Citation Metrics

Metric	Value
Publication Count	24
Citation Count	333
h-index	10

Publications:

Research misconduct tests: putting patients' interests first.

DOI: 10.1016/j.jclinepi.2021.07.016

Year: 2021

Assessing Research Misconduct in Randomized Controlled Trials.

DOI: 10.1097/AOG.0000000000004513

Year: 2021

Methods to assess research misconduct in health-related research: A scoping review.

DOI: 10.1016/j.jclinepi.2021.05.012

Year: 2021

An investigation of seven other publications by the first author of a retracted paper due to doubts about data integrity.

DOI: 10.1016/j.ejogrb.2021.04.018

Year: 2021

To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome?

DOI: 10.1093/humupd/dmaa031

Year: 2020

Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.

DOI: 10.1002/14651858.cd001122.pub5

Year: 2020

Data integrity of 35 randomised controlled trials in women' health.

DOI: 10.1016/j.ejogrb.2020.04.016

Year: 2020

Letter of response (2) - Data integrity of 35 randomised controlled trials in women' health.

DOI: 10.1016/j.ejogrb.2020.08.050

Year: 2020

Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?

DOI: 10.1093/humrep/deaa052

Year: 2020

Letter of response - Data integrity of 35 randomised controlled trials in women' health.

DOI: 10.1016/j.ejogrb.2020.06.007

Year: 2020

What Role Does Patient Education Play in Specialized Gynecology?

What are the Risk Factors for Lactic Acidosis in Gynecological Patients?

What Are Lubricants?

What are the Benefits of Telehealth Consultations?

Who Can Benefit from Group Therapy?

Are There Side Effects?

Why is Postoperative Drainage Necessary?

How is Increased Blood Volume Managed?

When Should a Couple Seek Help for Fertility Issues?

What is Cefalexin?

Partnered Content Networks

Relevant Topics